BCL2 and gastric cancer: In cisplatin-resistant gastric cancer, production of miR-21 by TAMs was shown which decreased PTEN activation, and enhanced activation of the PI3K/AKT pathway and production of Bcl-2, therefore, decreasing apoptosis rate and cisplatin sensitivity of gastric cancer cells [60].